Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS

IST:GENIL (Turkey)  
₺ 62.60 (+0.56%) May 24
41.48
P/B:
3.88
Market Cap:
₺ 18.78B ($ 583.26M)
Enterprise V:
₺ 19.35B ($ 601.08M)
Volume:
1.14M
Avg Vol (2M):
1.95M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS ( ) from 2021 to May 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Gen Ilac Veglik Urunleri Sanayi ve Ticaret AS stock (IST:GENIL) PE ratio as of May 25 2024 is 41.48. More Details

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) PE Ratio (TTM) Chart

To

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) PE Ratio (TTM) Historical Data

Total 718
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 8
Gen Ilac Veglik Urunleri Sanayi ve Ticaret AS PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 41.5 2024-03-15 48.4
2024-05-24 41.5 2024-03-14 47.7
2024-05-23 41.3 2024-03-13 46.2
2024-05-22 40.8 2024-03-12 48.4
2024-05-21 41.4 2024-03-11 50.7
2024-05-20 42.7 2024-03-08 50.3
2024-05-17 40.9 2024-03-07 50.4
2024-05-16 41.0 2024-03-06 49.7
2024-05-15 39.0 2024-03-05 48.6
2024-05-14 37.0 2024-03-04 49.0
2024-05-13 37.3 2024-03-01 49.0
2024-05-10 37.8 2024-02-29 47.6
2024-05-09 37.9 2024-02-28 46.4
2024-05-08 39.3 2024-02-27 47.2
2024-05-07 39.7 2024-02-26 47.0
2024-05-06 39.9 2024-02-23 48.7
2024-05-03 38.6 2024-02-22 45.7
2024-05-02 36.9 2024-02-21 47.4
2024-04-30 36.4 2024-02-20 48.6
2024-04-29 37.2 2024-02-19 49.0
2024-04-26 38.3 2024-02-16 48.9
2024-04-25 38.1 2024-02-15 46.3
2024-04-24 38.0 2024-02-14 44.1
2024-04-22 39.3 2024-02-13 41.0
2024-04-19 38.8 2024-02-12 41.1
2024-04-18 38.4 2024-02-09 39.7
2024-04-17 37.4 2024-02-08 38.4
2024-04-16 38.0 2024-02-07 35.5
2024-04-15 38.4 2024-02-06 36.0
2024-04-08 40.8 2024-02-05 35.1
2024-04-05 42.2 2024-02-02 34.4
2024-04-04 43.1 2024-02-01 35.0
2024-04-03 43.4 2024-01-31 35.0
2024-04-02 44.5 2024-01-30 34.9
2024-04-01 46.2 2024-01-29 34.9
2024-03-29 44.3 2024-01-26 34.8
2024-03-28 44.3 2024-01-25 33.9
2024-03-27 43.9 2024-01-24 33.5
2024-03-26 43.9 2024-01-23 32.4
2024-03-25 45.9 2024-01-22 32.2
2024-03-22 48.4 2024-01-19 32.2
2024-03-21 49.9 2024-01-18 31.8
2024-03-20 51.6 2024-01-17 31.6
2024-03-19 51.0 2024-01-16 31.4
2024-03-18 48.4 2024-01-15 31.2

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.